Page last updated: 2024-09-05

tv3326 and ass234

tv3326 has been researched along with ass234 in 2 studies

Compound Research Comparison

Studies
(tv3326)
Trials
(tv3326)
Recent Studies (post-2010)
(tv3326)
Studies
(ass234)
Trials
(ass234)
Recent Studies (post-2010) (ass234)
15011909

Protein Interaction Comparison

ProteinTaxonomytv3326 (IC50)ass234 (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.35
CholinesteraseHomo sapiens (human)2.092
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.043
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)0.0052
Amine oxidase [flavin-containing] AHomo sapiens (human)0.0169
AcetylcholinesteraseHomo sapiens (human)1.0933
Amine oxidase [flavin-containing] BHomo sapiens (human)0.8093
Beta-secretase 1Homo sapiens (human)0.46
CholinesteraseEquus caballus (horse)0.46

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kumar, A; Mishra, P; Panda, G1
do Carmo Carreiras, M; Ismaili, L; Marco-Contelles, J1

Reviews

2 review(s) available for tv3326 and ass234

ArticleYear
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
    Bioorganic & medicinal chemistry, 2019, 03-15, Volume: 27, Issue:6

    Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents

2019
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.
    Bioorganic & medicinal chemistry letters, 2020, 02-01, Volume: 30, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Cholinesterases; Humans; Ligands; Monoamine Oxidase; Neuroprotective Agents; Oxidative Stress; Pargyline; Propylamines

2020